JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266527

Human FKBP2 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

FKBP2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 8 bp deletion in exon 2.

View Alternative Names

13 kDa FK506-binding protein, 13 kDa FKBP, EC 5.2.1.8, FK506 binding protein 2 (13kD), FK506 binding protein 2 13kDa, FK506-binding protein 2, FK506-binding protein, T-cell, 13-KD, FKBP-13, FKBP2_HUMAN, Immunophilin FKBP13, PPIase, PPIase FKBP2, Peptidyl-prolyl cis-trans isomerase FKBP2, Proline isomerase, Rapamycin binding protein, Rotamase, peptidyl-prolyl cis-trans isomerase

1 Images
Sanger Sequencing - Human FKBP2 knockout HEK-293T cell line (AB266527)
  • Sanger seq

Unknown

Sanger Sequencing - Human FKBP2 knockout HEK-293T cell line (AB266527)

Homozygous : 8 bp deletion in exon 2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 8 bp deletion in exon 2

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266527-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266527 Human FKBP2 knockout HEK-293T cell line", "number":"AB266527-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266527-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266527 Human FKBP2 knockout HEK-293T cell line", "number":"AB266527-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
FKBP2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FKBP2 also known as FK506-binding protein 2 is a member of the immunophilin protein family and weighs approximately 15 kDa. Mechanically FKBP2 acts as a peptidyl-prolyl cis-trans isomerase facilitating the proper folding of proteins by catalyzing the interconversion between isomeric forms of proline in polypeptide chains. It is expressed mainly in the endoplasmic reticulum demonstrating strong involvement in cellular protein folding mechanisms. FKBP2 binds FK506 a macrolide with immunosuppressive properties which has identified its importance in various cell functions.
Biological function summary

FKBP2 plays significant roles in protein folding and trafficking within cells. It regulates calcium homeostasis by interacting with the calcium channels of the endoplasmic reticulum. FKBP2 often associates with complex components involved in signal transduction and cellular stress response emphasizing its roles in maintaining cellular equilibrium and reacting to external protein demands. This protein acts in coordination with other immunophilins providing a multifaceted approach to the management of protein conformation and cellular signaling.

Pathways

FKBP2 operates significantly within the protein folding and stress response pathways. It is closely related to the calcineurin signaling pathway primarily due to its interaction with immunosuppressant FK506 and its effect on calcineurin activity. In addition FKBP2 works alongside proteins like FKBP51 and HSP90 to ensure the proper functional configuration of molecular chaperones facilitating cellular adaptation under stress conditions and during protein synthesis.

FKBP2 has connections to neurodegenerative disorders and cardiovascular diseases revealing its impact on critical health concerns. Dysfunctions in FKBP2 may lead to improper protein folding linked to neurodegenerative conditions like Alzheimer's disease through its interaction with tau proteins. Furthermore its role in calcium regulation ties FKBP2 to cardiovascular disorders where any imbalance can lead to compromised cardiac function suggesting its involvement with cardiac-specific proteins such as SERCA2.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com